Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial
| dc.article.end-page | 23 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1371/JOURNAL.PMED.1004360 | en |
| dc.contributor.author | Z Moodie | en |
| dc.contributor.author | E Andersen-Nissen | en |
| dc.contributor.author | Nicole Grunenberg | en |
| dc.contributor.author | One B Dintwe | en |
| dc.contributor.author | Fatima Laher | en |
| dc.contributor.author | E et al | en |
| dc.date.accessioned | 2025-01-25T15:43:22Z | |
| dc.date.available | 2025-01-25T15:43:22Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 1549-1277 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/43667 | |
| dc.journal.title | Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial | en |
| dc.journal.volume | 21 | en |
| dc.publisher | PUBLIC LIBRARY SCIENCE | en |
| dc.title | Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 3.1 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client